The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
Open accessAbstract
DNA methylation is tightly regulated throughout mammalian development, and altered DNA methylation patterns are a general hallmark of cancer. The methylcytosine dioxygenase TET2 is frequently mutated in hematological disorders, including acute myeloid leukemia (AML), and has been suggested to protect CG dinucleotide (CpG) islands and promoters from aberrant DNA methylation. In this study, we present a novel Tet2-dependent leukemia mouse model that closely recapitulates gene expression profiles and hallmarks of human AML1-ETO-induced AML. Using this model, we show that the primary effect of Tet2 loss in preleukemic hematopoietic cells is progressive and widespread DNA hypermethylation affecting up to 25% of active enhancer elements. In contrast, CpG island and promoter methylation does not change in a Tet2-dependent manner but increases relative to population doublings. We confirmed this specific enhancer hypermethylation phenotype in human AML patients with TET2 mutations. Analysis of immediate gene expression changes reveals rapid deregulation of a large number of genes implicated in tumorigenesis, including many down-regulated tumor suppressor genes. Hence, we propose that TET2 prevents leukemic transformation by protecting enhancers from aberrant DNA methylation and that it is the combined silencing of several tumor suppressor genes in TET2 mutated hematopoietic cells that contributes to increased stem cell proliferation and leukemogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compound mutant cells also exhibited greater serial colony-forming activity than Tet2KO cells, which showed extended serial replating activity, in line with past reports (17, 32).”
From PU.1-Dependent Enhancer Inhibition Separates Tet2 -Deficient Hematopoiesis from Malignant Transformation (2022) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistently, TET2-mutant immature and myeloid cells present with hypermethylation of active enhancers and perturbed TF activity (28, 32, 53).”
From PU.1-Dependent Enhancer Inhibition Separates Tet2 -Deficient Hematopoiesis from Malignant Transformation (2022) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“Hypermethylation at enhancer elements coincides with leukaemogenesis in haematopoietic progenitor cells of TET2−/− mice expressing the AML–ETO9a fusion.40”
From Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia (2018) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
An atlas of active enhancers across human cell types and tissues
The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., et al. (2014) · Nature · doi:10.1038/nature12787 · Cited by 2,550
Self-citationGenome-scale DNA methylation maps of pluripotent and differentiated cells
Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., Jaffe, D. B., et al. (2008) · Nature · doi:10.1038/nature07107 · Cited by 2,536
Function and information content of DNA methylation
Schübeler, D. (2015) · Nature · doi:10.1038/nature14192 · Cited by 2,060
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776
Self-citationDNA-binding factors shape the mouse methylome at distal regulatory regions
Stadler, M. B., Murr, R., Burger, L., Ivanek, R., Lienert, F., Schöler, A., Nimwegen, E. V., Wirbelauer, C., Oakeley, E. J., Gaidatzis, D., et al. (2011) · Nature · doi:10.1038/nature10716 · Cited by 1,383
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R. D., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,340
Flagged first, then by citations
Cited by
Sorted by citations
The diverse roles of DNA methylation in mammalian development and disease
Greenberg, M., & Bourc’his, D. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0159-6 · Cited by 2,272
Role of TET enzymes in DNA methylation, development, and cancer
Rasmussen, K. D., & Helin, K. (2016) · Genes & Development · doi:10.1101/gad.276568.115 · Cited by 1,040
Self-citationDNA Methylation in Cancer and Aging
Klutstein, M., Nejman, D., Greenfield, R., & Cedar, H. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3278 · Cited by 810
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Cimmino, L., Dolgalev, I., Wang, Y., Yoshimi, A., Martin, G. H., Wang, J., Ng, V., Xia, B., Witkowski, M. T., Mitchell-Flack, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.032 · Cited by 707
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Sperling, A. S., Gibson, C. J., & Ebert, B. L. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.112 · Cited by 706
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Bowman, R. L., Busque, L., & Levine, R. L. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.01.011 · Cited by 448
The DNA methylation landscape of advanced prostate cancer
Zhao, S. G., Chen, W. S., Li, H., Foye, A., Zhang, M., Sjöström, M., Aggarwal, R. R., Playdle, D., Liao, A., Alumkal, J. J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0648-8 · Cited by 357
The DNA methylation landscape in cancer
Skvortsova, K., Stirzaker, C., & Taberlay, P. C. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190037 · Cited by 325
Molecular biomarkers in acute myeloid leukemia
Prada‐Arismendy, J., Arroyave-Ospina, J. C., & Röthlisberger, S. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.08.005 · Cited by 317
Tet2 restrains inflammatory gene expression in macrophages
Cull, A. H., Snetsinger, B., Buckstein, R., Wells, R. A., & Rauh, M. J. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.08.001 · Cited by 295
The roles of miRNA, lncRNA and circRNA in the development of osteoporosis
Yang, Y., Yujiao, W., Wang, F., Linhui, Y., Guo, Z., Zhichen, W., Zirui, W., & Wang, S. (2020) · Biological Research · doi:10.1186/s40659-020-00309-z · Cited by 289
DNA methylation in mammalian development and disease
Smith, Z. D., Hetzel, S., & Meissner, A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00760-8 · Cited by 310
Zhang, X., Su, J., Jeong, M., Ko, M., Huang, Y., Park, H. J., Guzman, A., Lei, Y., Huang, Y.-H., Rao, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3610 · Cited by 258
Ascorbic Acid in Cancer Treatment: Let the Phoenix Fly
Shenoy, N. K., Creagan, E. T., Witzig, T. E., & Levine, M. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.014 · Cited by 208
Dnmt3a and Dnmt3b Associate with Enhancers to Regulate Human Epidermal Stem Cell Homeostasis
Rinaldi, L., Datta, D., Serrat, J., Morey, L., Solanas, G., Avgustinova, A., Blanco, E., Pons, J., Matallanas, D., von Kriegsheim, A., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.06.020 · Cited by 201
Domínguez, P. M., Ghamlouch, H., Rosikiewicz, W., Kumar, P., Béguelin, W., Fontán, L., Rivas, M. A., Pawlikowska, P., Armand, M., Mouly, E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0657 · Cited by 188
Self-citationThe Loss of TET2 Promotes CD8+ T Cell Memory Differentiation
Carty, S. A., Gohil, M., Banks, L. B., Cotton, R. M., Johnson, M. E., Stelekati, E., Wells, A. D., Wherry, E. J., Koretzky, G. A., & Jordan, M. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700559 · Cited by 175
Mechanisms that regulate the activities of TET proteins
Joshi, K., Liu, S., Breslin, P., & Zhang, J. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04396-x · Cited by 177
Loss of TET2 and TET3 in regulatory T cells unleashes effector function
Yue, X., Lio, C. J., Samaniego‐Castruita, D., Li, X., & Rao, A. (2019) · Nature Communications · doi:10.1038/s41467-019-09541-y · Cited by 159
Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies
Lio, C. J., Yuita, H., & Rao, A. (2019) · Blood · doi:10.1182/blood.2019791475 · Cited by 152
Zhang, Y. W., Wang, Z., Xie, W., Cai, Y., Xia, L., Easwaran, H., Luo, J., Yen, R.-W. C., Li, Y., & Baylin, S. B. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.013 · Cited by 148
DNA methylation as a transcriptional regulator of the immune system
Morales‐Nebreda, L., McLafferty, F. S., & Singer, B. D. (2018) · Translational research · doi:10.1016/j.trsl.2018.08.001 · Cited by 141
TET2 coactivates gene expression through demethylation of enhancers
Wang, L., Ozark, P. A., Smith, E. R., Zhao, Z., Marshall, S. A., Rendleman, E. J., Piunti, A., Ryan, C., Whelan, A. L., Helmin, K. A., et al. (2018) · Science Advances · doi:10.1126/sciadv.aau6986 · Cited by 137
Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones
Challen, G., & Goodell, M. A. (2020) · Blood · doi:10.1182/blood.2020006510 · Cited by 131
Clonal hematopoiesis: Mutation-specific adaptation to environmental change
Florez, M. A., Tran, B. T., Wathan, T. K., DeGregori, J., Pietras, E. M., & King, K. Y. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.05.006 · Cited by 129
Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved
Long, H. K., King, H. W., Patient, R. K., Odom, D. T., & Klose, R. J. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw258 · Cited by 135
Cooperative Action between SALL4A and TET Proteins in Stepwise Oxidation of 5-Methylcytosine
Xiong, J., Zhang, Z., Chen, J., Huang, H., Xu, Y., Ding, X., Zheng, Y., Nishinakamura, R., Xu, G.-L., Wang, H., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.013 · Cited by 127
Al-harbi, S., Aljurf, M. D., Mohty, M., Almohareb, F. I., & Ahmed, S. O. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000168 · Cited by 126
Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets
Mishra, S. K., Millman, S. E., & Zhang, L. (2022) · Blood · doi:10.1182/blood.2022018092 · Cited by 127
Crosstalk between metabolism and epigenetics during macrophage polarization
Zhang, K., & Jagannath, C. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00575-9 · Cited by 137
Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
Shenoy, N., Bhagat, T., Nieves, E., Stenson, M., Lawson, J., Choudhary, G. S., Habermann, T., Nowakowski, G., Singh, R., Wu, X., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.65 · Cited by 111
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal
Li, Y., Xue, M., Deng, X., Dong, L., Nguyen, L. X. T., Ren, L., Han, L., Li, C., Xue, J., Zhao, Z., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.07.001 · Cited by 115
Methylation biomarkers for early cancer detection and diagnosis: Current and future perspectives
Ibrahim, J., Peeters, M., Camp, G. V., & de Beeck, K. O. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.10.015 · Cited by 116
Epigenetic Priming in Cancer Initiation
Vicente‐Dueñas, C., Hauer, J., Cobaleda, C., Borkhardt, A., & Sánchez-Garcı́a, I. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.04.007 · Cited by 107
Genetic and epigenetic determinants of diffuse large B-cell lymphoma
Bakhshi, T. J., & Georgel, P. T. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00389-w · Cited by 109
Tulstrup, M., Soerensen, M., Hansen, J. W., Gillberg, L., Needhamsen, M., Kaastrup, K., Helin, K., Christensen, K., Weischenfeldt, J., & Grønbæk, K. (2021) · Nature Communications · doi:10.1038/s41467-021-26093-2 · Cited by 108
Self-citationGarcia‐Manero, G., Montalban‐Bravo, G., Berdeja, J. G., Abaza, Y., Jabbour, E., Essell, J., Lyons, R. M., Ravandi, F., Maris, M., Heller, B., et al. (2017) · Cancer · doi:10.1002/cncr.30533 · Cited by 104
Tissue-specific DNA demethylation is required for proper B-cell differentiation and function
Orlanski, S., Labi, V., Reizel, Y., Spiro, A., Lichtenstein, M., Levin-Klein, R., Koralov, S. B., Skversky‐Blocq, Y., Rajewsky, K., Cedar, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604365113 · Cited by 103
Epigenetic Regulation of Genomic Stability by Vitamin C
Brabson, J. P., Leesang, T. E., Mohammad, S., & Cimmino, L. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.675780 · Cited by 111
Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
Zhao, Z., Chen, L., Dawlaty, M. M., Pan, F., Weeks, O. I., Zhou, Y., Cao, Z., Shi, H., Wang, J., Lin, L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.037 · Cited by 104
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Yang, X., Wong, M. P. M., & Ng, R. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184576 · Cited by 105
Sun, J., He, X., Zhu, Y., Ding, Z., Dong, H., Feng, Y., Du, J., Wang, H., Wu, X., Zhang, L., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.07.018 · Cited by 99
Montagner, S., Leoni, C., Emming, S., Chiara, G. D., Balestrieri, C., Barozzi, I., Piccolo, V., Togher, S., Ko, M., Rao, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.044 · Cited by 102
Chisholm, R. H., Lorenzi, T., & Clairambault, J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.06.009 · Cited by 99
Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia
Mingay, M., Chaturvedi, A., Bilenky, M., Cao, Q., Jackson, L., Hui, T., Moksa, M., Heravi-Moussavi, A., Humphries, R. K., Heuser, M., et al. (2018) · Leukemia · doi:10.1038/leu.2017.171 · Cited by 94
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
Yeaton, A. H., Cayanan, G., Loghavi, S., Dolgalev, I., Leddin, E. M., Loo, C. E., Torabifard, H., Nicolet, D., Wang, J., Corrigan, K., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1146 · Cited by 99
Shenoy, N. K., Bhagat, T. D., Cheville, J. C., Lohse, C. M., Bhattacharyya, S., Tischer, A., Machha, V. R., Gordon-Mitchell, S., Choudhary, G. S., Wong, L.-F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci98747 · Cited by 97
TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells
Rasmussen, K. D., Berest, I., Keβler, S., Nishimura, K., Simón-Carrasco, L., Vassiliou, G. S., Pedersen, M. T., Christensen, J., Zaugg, J. B., & Helin, K. (2019) · Genome Research · doi:10.1101/gr.239277.118 · Cited by 95
Self-citationThe Impact of DNA Methylation in Hematopoietic Malignancies
Guillamot, M., Cimmino, L., & Aifantis, I. (2016) · Trends in cancer · doi:10.1016/j.trecan.2015.12.006 · Cited by 96
Tet2 at the interface between cancer and immunity
Jiang, S. (2020) · Communications Biology · doi:10.1038/s42003-020-01391-5 · Cited by 89
Active DNA demethylation by DNA repair: Facts and uncertainties
Schuermann, D., Weber, A. R., & Schär, P. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.05.013 · Cited by 87
TET methylcytosine oxidases: new insights from a decade of research
Lio, C. J., Yue, X., López-Moyado, I. F., Tahiliani, M., Aravind, L., & Rao, A. (2020) · Journal of Biosciences · doi:10.1007/s12038-019-9973-4 · Cited by 80
Scourzic, L., Couronné, L., Pedersen, M. T., Della-Valle, V., Diop, M. K., Mylonas, E., Calvo, J., Mouly, E., Lopez, C. K., Martin, N., et al. (2016) · Leukemia · doi:10.1038/leu.2016.29 · Cited by 84
Self-citationPortraits of TET-mediated DNA hydroxymethylation in cancer
Jeschke, J., Collignon, É., & Fuks, F. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.01.004 · Cited by 76
High prevalence of focal and multi-focal somatic genetic variants in the human brain
Keogh, M. J., Wei, W., Aryaman, J., Walker, L., van den Ameele, J., Coxhead, J., Wilson, I., Bashton, M., Beck, J., West, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06331-w · Cited by 74
Namba-Fukuyo, H., Funata, S., Matsusaka, K., Fukuyo, M., Rahmutulla, B., Mano, Y., Fukayama, M., Aburatani, H., & Kaneda, A. (2016) · Oncotarget · doi:10.18632/oncotarget.13130 · Cited by 74
TET Methylcytosine Oxidases in T Cell and B Cell Development and Function
Tsagaratou, A., Lio, C. J., Yue, X., & Rao, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00220 · Cited by 76
Biology of IDH mutant cholangiocarcinoma
Wu, M., Shi, L., Merritt, J., Zhu, A. X., & Bardeesy, N. M. (2022) · Hepatology · doi:10.1002/hep.32424 · Cited by 71
Consequences of mutant TET2 on clonality and subclonal hierarchy
Hirsch, C. M., Nazha, A., Kneen, K. E., Abazeed, M. E., Meggendorfer, M., Przychodzen, B. P., Nadarajah, N., Ademà, V., Nagata, Y., Goyal, A., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0150-9 · Cited by 71
Chavakis, T., Wielockx, B., & Hajishengallis, G. (2021) · Annual Review of Physiology · doi:10.1146/annurev-physiol-052521-013627 · Cited by 75
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia
Micol, J., Pastore, A., Inoue, D., Duployez, N., Kim, E. H., Lee, S. C.-W., Durham, B. H., Chung, Y. R., Cho, H., Zhang, X. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms15429 · Cited by 73
Low Shear Stress Inhibited Endothelial Cell Autophagy Through TET2 Downregulation
Yang, Q., Li, X., Li, R., Peng, J., Zuo, W., Jiang, Z., Tang, X., Zhao, P., Wang, Y., & Wei, D. (2015) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1491-4 · Cited by 65
Hajishengallis, G., Li, X., Divaris, K., & Chavakis, T. (2022) · Periodontology 2000 · doi:10.1111/prd.12421 · Cited by 70
Orphan CpG islands define a novel class of highly active enhancers
Bell, J. S. K., & Vertino, P. M. (2017) · Epigenetics · doi:10.1080/15592294.2017.1297910 · Cited by 58
The Molecular Genetics of Myeloproliferative NeoplasmsPreprint
Marneth, A. E., & Mullally, A. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034876 · Cited by 65
ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer
Szczepanski, A. P., Zhao, Z., Sosnowski, T., Goo, Y. A., Bartom, E. T., & Wang, L. (2020) · Genome Medicine · doi:10.1186/s13073-020-00760-3 · Cited by 60
Dysregulation of TET2 in hematologic malignancies
Chiba, S. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2122-z · Cited by 62
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer
Koschmann, C. J., Núñez, F. J., Mendez, F., Brosnan‐Cashman, J. A., Meeker, A. K., Lowenstein, P. R., & Castro, M. G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2301 · Cited by 60
TET2: A cornerstone in normal and malignant hematopoiesis
Kunimoto, H., & Nakajima, H. (2020) · Cancer Science · doi:10.1111/cas.14688 · Cited by 56
Epigenetics in myelodysplastic syndromes
Heuser, M., Yun, H., & Thol, F. R. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.009 · Cited by 61
6mA-DNA-binding factor Jumu controls maternal-to-zygotic transition upstream of Zelda
He, S., Zhang, G., Wang, J., Gao, Y., Sun, R., Cao, Z., Chen, Z., Zheng, X.-D., Yuan, J., Luo, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10202-3 · Cited by 55
The DNA methylation landscape of hematological malignancies: an update
Blecua, P., Martinez‐Verbo, L., & Esteller, M. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12744 · Cited by 57
Nakauchi, Y., Azizi, A., Thomas, D., Corces, M. R., Reinisch, A., Sharma, R., Hernandez, D. C., Köhnke, T., Karigane, D., Fan, A. C., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0143 · Cited by 60
RNA modification systems as therapeutic targets
Zhang, L., Wei, J., Zou, Z., & He, C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01280-8 · Cited by 64
Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
Eriksson, A., Lennartsson, A., & Lehmann, S. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.009 · Cited by 62
DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
Sato, H., Wheat, J. C., Steidl, U. G., & Ito, K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00187 · Cited by 59
Rinaldi, L., Avgustinova, A., Martı́n, M., Datta, D., Solanas, G., Prats, N., & Benitah, S. A. (2017) · eLife · doi:10.7554/elife.21697 · Cited by 56
Expression and prognosis analysis of DNMT family in acute myeloid leukemia
Zhang, T., Zhang, L.-C., Xu, Z., & Zhou, J. (2020) · Aging · doi:10.18632/aging.103520 · Cited by 54
Clonal hematopoiesis and hematological malignancy
Dunn, W. G., McLoughlin, M. A., & Vassiliou, G. S. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180065 · Cited by 63
Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia
Corces, M. R., Chang, H. Y., & Majeti, R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00263 · Cited by 56
Broome, R., Chernukhin, I. V., Jamieson, S., Kishore, K., Papachristou, E. K., Mao, S.-Q., Tejedo, C. G., Mahtey, A., Theodorou, V., Groen, A. J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108776 · Cited by 50
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients
Giansanti, M., Karimi, T., Faraoni, I., & Graziani, G. (2021) · Cancers · doi:10.3390/cancers13061428 · Cited by 50
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation
Boy, M., Bisio, V., Zhao, L., Guidez, F., Schell, B., Lereclus, E., Henry, G., Villemonteix, J., Rodrigues‐Lima, F., Gagne, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36193-w · Cited by 51
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
Gambacorta, V., Gnani, D., Vago, L., & Micco, R. D. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00207 · Cited by 49
USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2
Chen, L., Smith, M. D., Lv, L., Nakagawa, T., Li, Z., Sun, S., Brown, N. G., Xiong, Y., & Xu, Y. (2020) · Science Advances · doi:10.1126/sciadv.abc9730 · Cited by 50
TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers
Li, S., Feng, J., Wu, F., Cai, J., Zhang, X., Wang, H., Fetahu, I. S., Iwanicki, I. J., Ma, D., Hu, T., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949425 · Cited by 46
Non-coding RNA-mediated epigenetic regulation of liver fibrosis
Yang, J., Tao, H., Deng, Z.-Y., Lü, C., & Li, . (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.004 · Cited by 47
Protein Interactions at Oxidized 5-Methylcytosine Bases
Pfeifer, G. P., Szabó, P. E., & Song, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.07.039 · Cited by 49
Mendes, K., Schmidhofer, S., Minderjahn, J., Glatz, D., Kiesewetter, C., Raithel, J., Wimmer, J., Gebhard, C., & Rehli, M. (2021) · Nature Communications · doi:10.1038/s41467-021-21661-y · Cited by 46
Duy, C., Teater, M. R., Garrett-Bakelman, F. E., Lee, T. C., Meydan, C., Glass, J. L., Li, M., Hellmuth, J. C., Mohammad, H. P., Smitheman, K. N., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0106 · Cited by 45
Reprogramming of DNA methylation at NEUROD2-bound sequences during cortical neuron differentiation
Hahn, M. A., Jin, S., Li, A. X., Liu, J., Huang, Z., Wu, X., Kim, B.-W., Johnson, J. S., Bilbao, A.-D. V., Tao, S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax0080 · Cited by 45
Enhancer dysfunction in leukemia
Bhagwat, A. S., Lu, B., & Vakoc, C. R. (2018) · Blood · doi:10.1182/blood-2017-11-737379 · Cited by 45
Lian, H., Li, W., & Jin, W. (2016) · Oncotarget · doi:10.18632/oncotarget.11412 · Cited by 45
Cher, C. Y., Leung, G. M., Au, C. H., Chan, T., Ma, E. S. K., Sim, J., Gill, H., Lie, A. K. W., Liang, R. H. S., Wong, K. F., et al. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.51 · Cited by 43
Reilly, B. M., Tanaka, T. N., Diep, D. H., Yeerna, H., Tamayo, P., Zhang, K., & Bejar, R. L. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000192 · Cited by 43
Epigenetic dysregulation ofTET2in human glioblastoma
García, M. G., Carella, A., Urdinguio, R. G., Bayón, G. F., López, V., Tejedor, J. R., Sierra, M., Toraño, E. G., Santamarina‐Ojeda, P., Pérez, R. F., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25406 · Cited by 44
Mercher, T., & Schwaller, J. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00401 · Cited by 42
Immunometabolic control of hematopoiesis
Hajishengallis, G., Li, X., & Chavakis, T. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100923 · Cited by 43
Vitamin C boosts DNA demethylation in TET2 germline mutation carriers
Taira, A., Palin, K., Kuosmanen, A., Välimäki, N., Kuittinen, O. M., Kuismin, O., Kaasinen, E., Rajamäki, K., & Aaltonen, L. A. (2023) · Clinical Epigenetics · doi:10.1186/s13148-022-01404-6 · Cited by 43
Enhancer DNA methylation in acute myeloid leukemia and myelodysplastic syndromes
Benetatos, L., & Vartholomatos, G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2783-2 · Cited by 42
Metadata
- Authors
- Rasmussen, K. D., Jia, G., Johansen, J. V., Pedersen, M. T., Rapin, N., Bagger, F. O., Porse, B. T., Bernard, O. A., Christensen, J., & Helin, K.
- Affiliations
- University of Copenhagen (DK)
- Inserm (FR)
- Corresponding author
- Helin, Kristian
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-04-17
- Volume
- 29
- Issue
- 9
- Pages
- 910-922
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC4421980
- OpenAlex
- W2169012047
- Cited by
- 270
- References
- 53
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 21 · 2023: 19 · 2022: 23 · 2021: 23 · 2020: 39 · 2019: 27 · 2018: 25 · 2017: 24 · 2016: 32 · 2015: 7
- Type
- posted content
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Genes & Development (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Danish Medical Research Council (1333-00120B)
- European Research Council (294666_DNAMET)
- Danish Cancer Society, Danish National Research Foundation (DNRF 82)
- Danish Council for Strategic Research
- Novo Nordisk Foundation
- Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- TET2, DNA hypermethylation, enhancer methylation, acute myeloid leukemia, AML1-ETO, leukemogenesis, hematopoietic cells, tumor suppressor, CpG islands, promoter methylation, DNA demethylation, leukemia mouse model, stem cell proliferation
- MeSH terms
- Animals, DNA-Binding Proteins, Enhancer Elements, Genetic, Hematopoietic Stem Cells, Humans, Mutation, Proto-Oncogene Proteins, Translocation, Genetic, Gene Expression Regulation, Neoplastic, DNA Methylation, Cell Proliferation, Dioxygenases, Mice, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
